This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q1 FY27: revenue up 22 percent, PAT down 60 percent; Rs 2 dividend; promoter warrants
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.0 pts more than Nifty Microcap 250 and 8.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krsnaa Diagnostics Q1FY27 (consolidated): revenue up 22 percent to Rs 2,355 mn from Rs 1,926 mn YoY. Profit fell about 60 percent to Rs 165.5 mn from Rs 417.2 mn on higher finance and depreciation costs. EPS Rs 5.10 vs Rs 12.86. Board set Sept 18 record date for Rs 2 final dividend; AGM on Sept 28. Approved 16.21 lakh warrants to promoters at Rs 565 or floor price, whichever higher. Auditor flagged Rs 626.9 mn income tax demand.
Mixed quarter: strong revenue growth but sharp profit fall. Dividend positive. Watch promoter warrant dilution and pending Rs 626.9 mn tax case.
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹235.5 Cr | ₹193.0 Cr | +22.1% |
| Operating profit | ₹15.19 Cr | ₹23.46 Cr | −35.3% |
| Profit after tax | ₹16.55 Cr | ₹20.52 Cr | −19.3% |
| EBITDA margin | 24.6% | 26.6% | −2.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.